Picture of Generation Bio logo

GBIO — Generation Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Generation Bio Co reports results for the quarter ended in March - Earnings Summary

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted loss
of 46 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 45
cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Generation Bio Co's reported EPS for the quarter was a loss
of 46 cents​.
* The mean earnings estimate of analysts had risen by
about 13.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Generation Bio Co shares had risen by 8.4% this quarter and
gained 8.8% so far this year.
* The company reported a quarterly loss of $25.56 million.
* Wall Street's median 12-month price target for Generation Bio
Co is $40.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 12:49 a.m. GMT.
​All figures in US dollars

Recent news on Generation Bio

See all news